CClinicalTrials.gg
CompletedNCT06975163Updated May 22, 2025

Effectiveness of Mindfulness-Based Intervention in Reducing Stigma Stress Among Parents of Autistic Children

An interventional study of Mindfulness-Based Stigma Stress Reduction (MBSSR) program in Autism Spectrum Disorder, sponsored by Education University of Hong Kong. Completed at 1 site in Hong Kong. Per ClinicalTrials.gov, last updated 2025-05-22.

Sponsored by Education University of Hong Kong · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Aug 2024, registered May 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
51
Allocation
Randomized
Sex
All
01

Study summary

Autism Spectrum Disorder (ASD) is a lifelong neurodevelopmental condition that usually becomes apparent in early childhood. Those diagnosed with ASD commonly struggle with social communication and behavioral regulation, often facing widespread societal stigma across different cultures. This prejudice extends beyond the affected children to their parents, who are routinely subjected to baseless blame and viewed as incapable of proper parenting. Such persistent negative perceptions can foster profound emotional suffering and chronic stress linked to societal judgment.

To date, there are no empirically supported interventions specifically aimed at alleviating stigma-induced stress in parents of autistic children. Nevertheless, studies in related fields indicate that mindfulness-based strategies could offer a potential coping mechanism. Addressing this gap, the current research presents a newly developed 4-week Mindfulness-Based Stigma Stress Reduction (MBSSR) program tailored for these parents. Using a randomized controlled trial, participants were divided into an MBSSR group or a waitlist control group, with both undergoing standardized evaluations at three distinct time points.

Read the detailed description

Autism Spectrum Disorder (ASD) is a well-known neurodevelopmental condition that emerges in early childhood and continues into adulthood. Children with ASD frequently face social and behavioral difficulties, and research indicates that stigma surrounding autism is prevalent in many societies. These children are sometimes mistakenly perceived as deliberately unruly, resulting in social prejudice and exclusion. This stigma also affects their parents, who endure societal judgment due to their emotional and biological ties to their children. Parents may be wrongly blamed for passing on "faulty" genes or accused of causing their child's condition. Additionally, they are often labeled as incompetent caregivers and criticized for failing to properly handle their child's behavior. Prolonged exposure to such bias can trigger deep-seated shame and psychological distress, leading to persistent stress linked to stigma.

Although stigma-related stress significantly impacts parents of autistic children, there are currently no scientifically validated interventions specifically designed to help them manage it. However, studies in similar areas propose that mindfulness practices may help individuals deal with stigma-induced stress. To bridge this research gap, this study introduces a novel 4-week Mindfulness-Based Stigma Stress Reduction (MBSSR) program tailored for parents of children with autism in Hong Kong. Using a randomized controlled trial approach, participants were divided into either the MBSSR treatment group or a waitlist control group, with both groups undergoing standardized evaluations at three separate intervals.

02

Conditions studied

  • Autism Spectrum Disorder

Keywords

  • Mindfulness
  • Stigma stress
  • Parents
03

In context

Autism Spectrum Disorder

1,727 studies on the registry are indexed under Autism Spectrum Disorder; 504 are open to participants now.

This study's enrollment of 51 is close to the median of 52 across 1,371 interventional studies indexed under Autism Spectrum Disorder.

Browse Autism Spectrum Disorder studies →

Lead sponsor

Education University of Hong Kong is the lead sponsor of 35 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Having a child formally diagnosed with Autism Spectrum Disorder (ASD) under Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) criteria by a registered medical practitioner
  • Acting as the principal caregiver for the child
  • Having the ability to read and write in Chinese
  • Demonstrating the experience of stigma stress on the Family Stigma Stress Scale, defined as agreeing with item(s) that gauge perceived stigma harm and disagreeing with item(s) that evaluate perceived coping resources

Exclusion criteria

Exclusion Criteria:

  • Having participated in any mindfulness-based programs before
  • Currently using psychiatric medications or receiving mental health services from professionals
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
51 participants (actual)

Study arms

  • Experimental
    Mindfulness-Based Stigma Stress Reduction (MBSSR) group

    Participants in the MBSSR group received a 4-week MBSSR program immediately after randomization. Participants completed the post-intervention assessment right after the intervention and the follow-up assessment one month after the intervention.

    Behavioral: Mindfulness-Based Stigma Stress Reduction (MBSSR) program

  • No intervention
    Waitlist control group

    Participants in the waitlist control group waited for 4 weeks without the Mindfulness-Based Stigma Stress Reduction (MBSSR) program. Participants completed the post-intervention assessment and the follow-up assessment simultaneously with the MBSSR group. After completing the follow-up assessment, the waitlist control participants started the MBSSR program (equivalent to that of the MBSSR group).

Interventions

  • BehavioralMindfulness-Based Stigma Stress Reduction (MBSSR) program

    The MBSSR program was developed by modifying elements from the Mindfulness-Based Stress Reduction (MBSR) and Mindfulness-Based Cognitive Therapy (MBCT) programs to create a distinct mindfulness intervention targeted at alleviating stigma stress among parents of autistic children. This program consisted of four group sessions, each incorporating mindfulness practices, group discussions, and activities that helped participants apply mindfulness principles to their daily lives.

06

What researchers measure

Primary outcomes

  1. Change from Baseline Assessment in Stigma Stress on the Stigma Stress Scale at Post-Intervention Assessment and Follow-up Assessment

    The Stigma Stress Scale was utilized to assess perceived stigma harm and perceived coping resources on a 5-point scale where 1 indicated "strong disagreement" and 5 indicated "strong agreement".

    Time frame: Before intervention, immediately after intervention, and one month after intervention

Secondary outcomes

  1. Change from Baseline Assessment in Well-being on the World Health Organization Well-Being Index at Post-Intervention Assessment and Follow-up Assessment

    The World Health Organization Well-Being Index was utilized to assess well-being on a 6-point scale where 0 indicated "at no time" and 5 indicated "all of the time".

    Time frame: Before intervention, immediately after intervention, and one month after intervention

  2. Change from Baseline Assessment in Caregiving Gain on the Positive Aspects of Caregiving at Post-Intervention Assessment and Follow-up Assessment

    The Positive Aspects of Caregiving was utilized to assess caregiving gain on a 5-point scale where 1 indicated "disagree a lot" and 5 indicated "agree a lot".

    Time frame: Before intervention, immediately after intervention, and one month after intervention

  3. Change from Baseline Assessment in Caregiving Burden on the Zarit Burden Interview at Post-Intervention Assessment and Follow-up Assessment

    The Short Version of the Zarit Burden Interview was utilized to assess caregiving burden on a 5-point scale where 1 indicated "never" and 5 indicated "nearly always".

    Time frame: Before intervention, immediately after intervention, and one month after intervention

  4. Change from Baseline Assessment in Mindful Parenting on the Interpersonal Mindfulness in Parenting Scale at Post-Intervention Assessment and Follow-up Assessment

    The Interpersonal Mindfulness in Parenting Scale was utilized to assess mindful parenting on a 5-point scale where 1 indicated "never true" and 5 indicated "always true".

    Time frame: Before intervention, immediately after intervention, and one month after intervention

  5. Change from Baseline Assessment in Child Autistic Symptoms on the Childhood Autism Rating Scale at Post-Intervention Assessment and Follow-up Assessment

    The Childhood Autism Rating Scale was utilized to assess child autistic symptoms on a 4-point scale where 1 indicated "normal" and 4 indicated "severely abnormal".

    Time frame: Before intervention, immediately after intervention, and one month after intervention

07

Study locations

1 site
  • The Education University of Hong Kong
    Hong Kong, Hong Kong
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06975163
Lead sponsor
Education University of Hong Kong
Responsible party
CHAN Ka Shing Kevin (Professor, Head of Department of Psychology, Education University of Hong Kong) — Principal investigator
First posted
May 16, 2025
Start date
Aug 1, 2024
Primary completion
Nov 30, 2024
Completion
Nov 30, 2024
Last update
May 22, 2025

Study contacts

Kevin Ka Shing Chan
principal investigator · The Education University of Hong Kong

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion